Investing in healthcare stocks like CRISPR Therapeutics and Hims & Hers Health could lead to significant returns. CRISPR's gene-editing technology is gaining FDA approval, while Hims & Hers' digital healthcare services show promising growth potential. Both stocks present opportunities for investors seeking high rewards.